124 related articles for article (PubMed ID: 33040689)
1. Does radical prostatectomy result in lower urinary tract symptom improvement in high-risk and locally advanced prostate cancer? A Single-center experience.
Papadopoulos G; Fragkoulis C; Stasinopoulos K; Stathouros G; Glykas I; Theocharis G; Lamprou S; Ntoumas K
Urologia; 2021 May; 88(2):110-114. PubMed ID: 33040689
[TBL] [Abstract][Full Text] [Related]
2. Improved lower urinary tract symptoms after robot-assisted radical prostatectomy: implications for survivorship, treatment selection and patient counselling.
Ahn T; Roberts MJ; Strahan A; Malone G; Paterdis J; Wood G; Heathcote P
BJU Int; 2019 May; 123 Suppl 5():47-53. PubMed ID: 31012991
[TBL] [Abstract][Full Text] [Related]
3. Robot-assisted simple prostatectomy for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: surgical technique and outcomes in a high-volume robotic centre.
Pokorny M; Novara G; Geurts N; Dovey Z; De Groote R; Ploumidis A; Schatteman P; de Naeyer G; Mottrie A
Eur Urol; 2015 Sep; 68(3):451-7. PubMed ID: 25887786
[TBL] [Abstract][Full Text] [Related]
4. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
[TBL] [Abstract][Full Text] [Related]
5. Management of low-risk prostate cancer in patients with enlarged glands and lower urinary tract symptoms: robotic total prostatectomy, a novel technique.
Pathak RA; Hemal AK
World J Urol; 2020 Apr; 38(4):829-836. PubMed ID: 31538243
[TBL] [Abstract][Full Text] [Related]
6. Lower urinary tract symptoms in patients with advanced prostate cancer: What are the outcomes of androgen deprivation therapy?
Akpayak IC; Shuaibu SI; Ofoha CG; Dakum NK; Ramyil VM; Onowa VE; Agbo CA; Nabasu LE; Galam ZZ
Niger Postgrad Med J; 2020; 27(1):49-53. PubMed ID: 32003362
[TBL] [Abstract][Full Text] [Related]
7. GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine.
Luo F; Sun HH; Su YH; Zhang ZH; Wang YS; Zhao Z; Li J
Lasers Med Sci; 2017 May; 32(4):895-901. PubMed ID: 28293871
[TBL] [Abstract][Full Text] [Related]
8. Improvement of severe baseline lower urinary tract symptoms following robotic-assisted laparoscopic prostatectomy.
Jazayeri SB; Sebrow D; Lavery H; Hobbs A; Levinson A; Samadi DB
Neurourol Urodyn; 2017 Jun; 36(5):1382-1386. PubMed ID: 27584690
[TBL] [Abstract][Full Text] [Related]
9. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
[TBL] [Abstract][Full Text] [Related]
10. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
[TBL] [Abstract][Full Text] [Related]
11. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
12. Diode laser ablation of prostate and channel transurethral resection of prostate in patients with prostate cancer and bladder outlet obstruction symptoms.
Javanmard B; Hassanzadeh Haddad A; Yaghoobi M; Lotfi B
Urol J; 2014 Sep; 11(4):1788-92. PubMed ID: 25194077
[TBL] [Abstract][Full Text] [Related]
13. The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer.
Kumar V; Toussi H; Marr C; Hough C; Javle P
BJU Int; 2004 Mar; 93(4):507-9. PubMed ID: 15008719
[TBL] [Abstract][Full Text] [Related]
14. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
15. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms.
Prabhu V; Taksler GB; Sivarajan G; Laze J; Makarov DV; Lepor H
J Urol; 2014 Feb; 191(2):412-7. PubMed ID: 23954581
[TBL] [Abstract][Full Text] [Related]
17. Urinary incontinence after radical prostatectomy: can men at risk be identified preoperatively?
Moore KN; Truong V; Estey E; Voaklander DC
J Wound Ostomy Continence Nurs; 2007; 34(3):270-9; quiz 280-1. PubMed ID: 17505246
[TBL] [Abstract][Full Text] [Related]
18. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
[TBL] [Abstract][Full Text] [Related]
19. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
Lee JH; Kim Y; Park YW; Lee DG
J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormonal therapy for volume reduction, lower urinary tract symptom relief and voiding symptoms in prostate cancer: leuprolide vs goserelin.
Yikilmaz TN; Ozturk E; Hizli F; Hamidi N; Basar H
Urol J; 2019 May; 16(2):157-161. PubMed ID: 30345497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
